Yohji Itoh

Yohji Itoh

Auto-generated profile, based on publicly available information

Yohji Itoh

Data Science and Innovation, R&D, AstraZeneca, Osaka, Japan

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 August 2011 in Physics in Medicine & Biology
Verified
Journal Article
Closed access
TST Shimozato
T Shimozato
YIYasunori Igarashi
Yasunori Igarashi
YIY Itoh
Y Itoh
NYNorio Yamamoto
Norio Yamamoto
KOK Okudaira
K Okudaira
Minoru UedaMinoru Ueda
Minoru Ueda
We aimed to estimate the scattered radiation from dental metallic crowns during head and neck radiotherapy by irradiating a jaw phantom with external photon beams. The phantom was composed of a dental metallic plate and hydroxyapatite embedded in polymethyl methacrylate. We used radiochromic film measurement and Monte Carlo simulation to calculate the radiation dose and dose distribution inside the phantom. To estimate dose variations in scattered radiation under different clinical situations, we altered the incident energy, field size, plate thickness, plate depth and plate material. The simulation results indicated that the dose at the incident side of the metallic dental plate was approximately 140% of that without the plate. The differences between dose distributions calculated with the radiation treatment-planning system (TPS) algorithms and the data simulation, except around the dental metallic plate, were 3% for a 4 MV photon beam. Therefore, we should carefully consider the dose distribution around dental metallic crowns determined by a TPS.

29 July 2023 in Journal of Infection and Chemotherapy
Verified
Journal Article
Open access
HOHiroshi Okada
Hiroshi Okada
KIKensuke Ishikawa
Kensuke Ishikawa
YIYohji Itoh
Yohji Itoh
YNYoshinori Noda
Yoshinori Noda
TETakashi Eto
Takashi Eto
EJEva Johnsson
Eva Johnsson
The aim of this study was to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of AZD7442 (tixagevimab/cilgavimab) in healthy Japanese adults. In this randomized, double-blind, placebo-controlled, phase 1 study, AZD7442 was administered intramuscularly (300 or 600 mg) or intravenously (300 or 1000 mg) to healthy Japanese adults. Primary endpoints were safety, tolerability, and pharmacokinetics. Anti-drug antibodies and neutralizing antibody activities were secondary endpoints. A total of 40 participants were randomized to receive AZD7442 (n = 30) or placebo (n = 10). Adverse events (AEs) occurred in 12 (40%) and 3 (30%) participants, respectively; there were no deaths, serious AEs, or AEs leading to study withdrawal. Tixagevimab and cilgavimab had mean half-lives of 82.1-95.9 and 77.9-92.0 days, respectively, which were generally similar regardless of administration route. SARS-CoV-2-neutralizing antibody titers were >4-fold higher than baseline levels from Day 8 to Day 211 in participants receiving AZD7442. AZD7442 was well tolerated in healthy Japanese adults, with predictable pharmacokinetics and an extended half-life, consistent with previous studies. gov, NCT04896541.

1 February 1995 in Journal of Clinical Pathology
Verified
Journal Article
Open access
PDF file
YKY C Ko
Y C Ko
Naofumi MukaidaNaofumi Mukaida
Naofumi Mukaida
TKT Kasahara
T Kasahara
SMS Muto
S Muto
KMK Matsushima
K Matsushima
TKTadashi Kawai
Tadashi Kawai
AIMS--To evaluate the influence of interleukin-8 (IL-8) and other inflammatory cytokines (IL-6, IL-1 beta and tumour necrosis factor alpha (TNF alpha)) on the occurrence of peritonitis in patients receiving continuous ambulatory peritoneal dialysis (CAPD). METHODS--The study population comprised 12 patients with peritonitis, 33 without peritonitis, all undergoing CAPD, and five patients undergoing peritoneal catheter implantation. Cytokine concentrations in dialysis fluid were determined by immunoassay and their values compared. RESULTS--Concentrations of both IL-8 (median 147 pg/ml, range 20-2273 pg/ml; n = 12) and IL-6 (median 1120 pg/ml, range 96-10,600 pg/ml) were substantially elevated, while the IL-1 beta concentration was lower and TNF alpha was not detectable in patients at diagnosis. The IL-6 concentration was also elevated in patients undergoing catheter implantation as well as in those with peritonitis. The IL-8 concentration, however, was elevated only upon infection. Intraperitoneal production of IL-8 was evident on determination of paired serum and dialysis fluid cytokine concentrations, and immunostaining of peritoneal cells with monoclonal anti-IL-8 antibody. CONCLUSIONS--These results suggest that determination of the IL-8 concentration in dialysis fluid maybe useful as a specific marker for following patients with peritonitis receiving CAPD.

13 November 2007 in International Congress Series
Verified
Journal Article
Closed access
RTR. Teradaira
R. Teradaira
YIY. Itoh
Y. Itoh
KKK. Kawai
K. Kawai
HIH. Ishikawa
H. Ishikawa
KOK. Ohashi
K. Ohashi
YNY. Nagamura
Y. Nagamura

27 July 2005
Verified
Conference Paper
Closed access
INIsao Nakanishi
Isao Nakanishi
HSH. Sakamoto
H. Sakamoto
YIY. Itoh
Y. Itoh
YFY. Fukui
Y. Fukui

11 October 2006
Verified
Conference Paper
Closed access
SLShi-Wook Lee
Shi-Wook Lee
KTK. Tanaka
K. Tanaka
YIY. Itoh
Y. Itoh
The paper describes subword-based approaches for open-vocabulary spoken document retrieval. First, the feasibility of subword units in spoken document retrieval is investigated, and our previously proposed sub-phonetic segment units are compared to typical subword units, such as syllables, phonemes, and triphones. Next, we explore the linear combination of retrieval score from multiple subword representations to improve retrieval performance. Experimental evaluation of open-vocabulary spoken document retrieval tasks demonstrates that our proposed sub-phonetic segment units are more effective than typical subword units, and the linear combination of multiple subword representations resulted in a consistent improvement in the F-measure.